Relationship Between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib

Kenta Yamamoto(Teikyo Heisei University), Mitsuhiro Fujishiro(Bunkyo University), Masanao Nakamura(Aichi Medical University), Yoji Ishizu(Nagoya University), Masatoshi Ishigami(Nagoya University), Hiroki Kawashima(Nagoya University Hospital), Takanori Ito(Aichi Medical University Hospital), Takashi Honda(Osaka Hospital), Ryoji Miyahara(Nagoya University Hospital), Teiji Kuzuya(Nagoya University)
Anticancer Research
February 1, 2020
10.21873/anticanres.13996
Cited by 27

Related Papers

Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images
|Gastric Cancer|2018|742
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer
|Digestive Endoscopy|2015|575
Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition)
|Digestive Endoscopy|2020|510
Diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks
|Gastrointestinal Endoscopy|2018|470